Chemical Compound
(1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20S,21S,25R,27S,28S,31S,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,28,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylic acid
CAS Registry Number
1397-89-3
Primary record
(1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20S,21S,25R,27S,28S,31S,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,28,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylic acid
- 库存
- 4,507 克
- 纯度
- 98.7 %
- CAS
- 1397-89-3
化合物标识与属性
- CAS
- 1397-89-3
- PubChem CID
- 6473721
- SMILES
- C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H](CC[C@@H]([C@H](C[C@H](CC(=O)O[C@H]([C@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O
- Canonical SMILES
- C[C@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)CC[C@H](O)[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O
名称与同义词
- Amphocin
- AmBiosone
- Amphotec
- Amphozone
- Fungizone
- Abelcet
- amphotericin b
- Mysteclin-F
- AmB/LIPOSOMAL
- Liposomal Amphotericin B
- Nebulisex Ambisome (TM)
- Amphotericin B & Nyotran
- AC1O6F28
- CHEBI:230189
- Nebulised Liposomal Amphotericin B
- NS-718
- NSC527017
- CID6473721
- Amphotericin B & Nyotran(Liposomal Nystatin)
- Lipid nanosphere that incorporates amphotericin B
- Ribbon form of lipid-stabilized amphotericin B aggregates
- Colloidal dispersion of cholesteryl sulfate and amphotericin B
- (1R,3S,5S,8S,9S,11R,15S,16S,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,8,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid
- (1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20S,21S,25R,27S,28S,31S,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-19,25,27,28,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylic acid
- (1S,3R,4E,6E,8E,10E,12E,14E,16E,18S,19R,20S,21S,25R,27S,28S,31S,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,28,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxylic acid
- [1R-(1R*,3S*,5R*,6R*,9R*,11R*,15S*,16R*,17R*,18S*,19E,21E,23E,25E,27E,29E,31E,33R*,35S*,36R*,37S*)]-33-[(3-Amino-3,6-dideoxy-.beta.-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-
- 1397-89-3
- AmB